Skip to main content
Premium Trial:

Request an Annual Quote

ACD Raises $22M in Equity Financing

NEW YORK (GenomeWeb) – Advanced Cell Diagnostics today said that it has raised $22 million in a Series C equity financing. 

The Hayward, California-based company will use the financing to accelerate its entry into the research and clinical diagnostics markets and to launch new technology platforms based on its RNAscope technology. 

The financing was led by Summit Partners. Kenson Ventures and existing investors Morningside Ventures and New Leaf Venture Partners also participated. In conjunction with the financing, Harrison Miller, a managing director at Summit Partners, is joining ACD's board. 

"The new funding will accelerate our pace of continued innovation and allow us to aggressively pursue our vision to bring RNAscope technologies to the forefront of precision medicine," ACD Founder, President, and CEO Yuling Luo said in a statement. 

The RNAscope technology is an automated multiplex chromogenic and fluorescent in situ hybridization platform capable of detecting and quantifying RNA biomarkers in formalin-fixed, paraffin-embedded tissues. It offers quantitative molecular detection along with morphological context in a single assay.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.